Marburg Virus Outbreak in Ethiopia: Africa CDC's Swift Response and Collaboration
A Critical Health Crisis in Ethiopia
On November 15, 2025, the Africa Centres for Disease Control and Prevention (Africa CDC) issued a statement regarding a confirmed outbreak of Marburg virus disease (MVD) in Jinka, Southern Ethiopia. This announcement highlights the swift and collaborative efforts of the Ethiopian government and health institutions in addressing this public health emergency.
Outbreak Details and Response
As of November 14, 2025, nine cases of Marburg virus have been reported in Jinka. The Ethiopian National Reference Laboratory confirmed the presence of the virus through clinical samples. Ongoing investigations and laboratory analyses are ongoing, revealing similarities to previous East African strains.
The initial alert about a suspected viral haemorrhagic fever was received by Africa CDC on November 12, 2025. The Federal Ministry of Health, Ethiopian Public Health Institute (EPHI), and regional health authorities sprang into action, implementing response measures:
- Enhanced Surveillance: Monitoring and tracking potential cases.
- Field Investigations: On-ground assessments to gather data and understand the outbreak's scope.
- Infection Prevention and Control: Implementing strict protocols to prevent further spread.
- Community Engagement: Educating and involving local communities in the response.
Africa CDC commends the authorities' swift action and transparent communication, enabling early confirmation and containment efforts.
Africa CDC's Role and Support
Africa CDC has been a long-standing partner of EPHI, significantly contributing to Ethiopia's molecular diagnostic and genomics surveillance capacity. This partnership is crucial for rapid response:
- Genome Sequencing: Africa CDC provided genome-sequencing equipment, reagents, and PCR detection kits, including specific Marburg assays.
- Training: Extensive training for laboratory personnel in genome sequencing, bioinformatics, biosafety, PPE use, and safe sample handling.
The core genomics facility at EPHI has been strengthened with support from Africa CDC and partners like the Global Fund, WHO, and the UK Health Security Agency, enhancing Ethiopia's overall outbreak readiness.
Research and Innovation
The Armauer Hansen Research Institute (AHRI), a leading Ethiopian research institution, has also received significant support from Africa CDC, strengthening its research and genomics capacity. This enables AHRI to play a central role in the Marburg outbreak response, fostering:
- Improved Care: Enhanced treatment and care for affected communities.
- Innovations: Development of critical innovations in Marburg prevention, diagnostics, and treatment.
Coordination and Cross-Border Cooperation
To further strengthen the response, Africa CDC and the Ministry of Health will integrate Marburg virus efforts with ongoing mpox preparedness and surveillance. This joint approach aims to optimize resources, accelerate early detection, and reduce regional spread.
Africa CDC Director-General, H.E. Dr. Jean Kaseya, will assess additional support needs and reinforce cross-border readiness with neighboring countries. Africa CDC will continue to collaborate closely with the Ethiopian government and partners for a rapid, coordinated, and effective response.
Looking Ahead
Further updates will be provided as more information becomes available. Africa CDC remains committed to supporting Ethiopia in this challenging time, ensuring a swift and effective response to protect public health.
About Africa CDC
Africa CDC is a public health agency of the African Union, dedicated to strengthening health systems and improving disease surveillance, emergency response, and disease control across Africa. Learn more at http://www.africacdc.org and connect with us on LinkedIn, Twitter, Facebook, and YouTube.
Media Contact
For media inquiries, contact Margaret Edwin, Director of Communication and Public Information, at EdwinM@africacdc.org.
